Low serum TGFα was also associated with a significantly higher pCR rate in group C (P = 0.045) while the remaining biomarkers showed no significant difference when adjusted for ER status and breast cancer type (Additional file 1: Table S3). This evidence concerns the gene ESR1 and breast carcinoma.